Gujarat, India

Chirag Patel



Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Chirag Patel: Innovator in Asymmetric Synthesis

Introduction

Chirag Patel is a notable inventor based in Gujarat, India. He has made significant contributions to the field of asymmetric synthesis, holding a total of 4 patents. His work focuses on the development of innovative processes for synthesizing complex chemical compounds.

Latest Patents

Chirag Patel's latest patents include an improved asymmetric synthesis of azaspiro compounds. This invention relates to the formation of intermediate compounds through a highly diastereoselective and enantio-enriched process. The method involves the addition of a cyclobutane carboxylate anion to a Davis-Ellman's imine, followed by reduction and cyclization. This results in the selective formation of azaspiro or diazaspiro intermediate compounds. Another significant patent is for the diastereoselective synthesis of vicinal diamines. This process utilizes highly regio- and diastereoselective addition of 2-azaallyl anions to N-tert-butanesulfinylimines, leading to the production of vicinal diamines.

Career Highlights

Chirag Patel is currently employed at Piramal Pharma Limited, where he continues to advance his research in asymmetric synthesis. His innovative approaches have garnered attention in the pharmaceutical industry, contributing to the development of new therapeutic compounds.

Collaborations

Chirag has collaborated with notable coworkers, including Rajender Reddy Leleti and Sharadsrikar Kotturi. Their combined expertise enhances the research and development efforts at Piramal Pharma Limited.

Conclusion

Chirag Patel's contributions to asymmetric synthesis and his innovative patents reflect his dedication to advancing the field of chemistry. His work not only showcases his inventiveness but also has the potential to impact pharmaceutical development significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…